Comparison of bromfenac 0.09% QD to nepafenac 0.1% TID after cataract surgery: pilot evaluation of visual acuity, macular volume, and retinal thickness at a single site

QR Code

Comparison of bromfenac 0.09% QD to nepafenac 0.1% TID after cataract surgery: pilot evaluation of visual acuity, macular volume, and retinal thickness at a single site

Melissa CableDiscover Vision Centers, Independence, MO, USAPurpose: The purpose of this study was to investigate the clinical outcomes of bromfenac ophthalmic solution 0.09% once daily (QD) and nepafenac 0.1% ophthalmic suspension three times daily following cataract extraction with posterior chambe...

Description complète

Enregistré dans:

Détails bibliographiques
Auteur principal:	Cable M
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2012
Sujets:	Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/5c54c28b907f468cb892a58b05516290
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Bromfenac 0.09% bioavailability in aqueous humor, prophylactic effect on cystoid macular edema, and clinical signs of ocular inflammation after phacoemulsification in a Mexican population
par: Palacio C, et autres
Publié: (2016)

Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK
par: Wang XJ, et autres
Publié: (2011)

Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%
par: Seenu M Hariprasad, et autres
Publié: (2009)

Efficacy and safety of bromfenac 0.09% and sodium hyaluronate 0.4% combination therapy, versus placebo in patients with pterygium I–III for clinical signs on ocular inflammation
par: Chávez-Mondragón E, et autres
Publié: (2019)

Effect of Cyclosporine 0.09% Treatment on Accuracy of Preoperative Biometry and Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery
par: Hovanesian JA, et autres
Publié: (2021)

Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease
par: Burade V, et autres
Publié: (2020)

Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies
par: Singh RP, et autres
Publié: (2017)

Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema
par: Giarmoukakis AK, et autres
Publié: (2020)

Hydration of Proton-conducting BaCe0.9Y0.1O3−δ by Decoupled Mass Transport
par: Dae-Kwang Lim, et autres
Publié: (2017)

Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy
par: Singh R, et autres
Publié: (2012)

Impact of dielectric properties on ionic conductivity of Ce0.9Sm0.1O1.95 via defect interaction
par: Sk. Anirban, et autres
Publié: (2021)

Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review
par: Sheppard JD
Publié: (2016)

Intrinsic stability of magnetic anti-skyrmions in the tetragonal inverse Heusler compound Mn1.4Pt0.9Pd0.1Sn
par: Rana Saha, et autres
Publié: (2019)

Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives
par: Yüksel B, et autres
Publié: (2017)

A randomized double-masked study to compare the ocular safety, tolerability, and efficacy of bromfenac 0.075% compared with vehicle in cataract surgery subjects
par: Hosseini K, et autres
Publié: (2016)

Topical nepafenac in the treatment of diabetic macular edema
par: David Callanan, et autres
Publié: (2008)

The efficacy of bromfenac ophthalmic solution 0.07% dosed once daily in achieving zero-to-trace anterior chamber cell severity following cataract surgery
par: Silverstein SM, et autres
Publié: (2014)

Low‐Temperature Protonic Ceramic Fuel Cells through Interfacial Engineering of Nanocrystalline BaCe0.7Zr0.1Y0.1Yb0.1O3−δ Electrolytes
par: Jun Gao, et autres
Publié: (2021)

The ocular distribution of 14C-labeled bromfenac ophthalmic solution 0.07% in a rabbit model
par: Baklayan GA, et autres
Publié: (2014)

Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits
par: Abayomi B Ogundele, et autres
Publié: (2010)

Choroidal and macular thickness changes induced by cataract surgery
par: Falcão MS, et autres
Publié: (2013)

Shaping triple-conducting semiconductor BaCo0.4Fe0.4Zr0.1Y0.1O3-δ into an electrolyte for low-temperature solid oxide fuel cells
par: Chen Xia, et autres
Publié: (2019)

Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment
par: Mizoguchi T, et autres
Publié: (2017)

Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits: response to authors
par: Chang-Lin J-E, et autres
Publié: (2011)

Effect of hemodialysis on visual acuity, intraocular pressure, and macular thickness in patients with chronic kidney disease
par: Chelala E, et autres
Publié: (2015)

Evolution of the intrinsic electronic phase separation in La0.6Er0.1Sr0.3MnO3 perovskite
par: Lili Chen, et autres
Publié: (2016)

Long-term follow-up after vitrectomy to treat idiopathic full-thickness macular holes: visual acuity and macular complications
par: Sakaguchi H, et autres
Publié: (2012)

Distinct macular thickness changes after femtosecond laser–assisted cataract surgery of age-related cataract and myopia with cataract
par: Yong Wang, et autres
Publié: (2018)

The Efficacy, Safety and Satisfaction Associated with Switching from Brinzolamide 1% and Brimonidine 0.1% to a Fixed Combination of Brinzolamide 1% and Brimonidine 0.1% in Glaucoma Patients
par: Hiromitsu Onoe, et autres
Publié: (2021)

Quantitative analysis of macular thickness following uneventful and complicated cataract surgery
par: Ak&ccedil;ay Bİ, et autres
Publié: (2012)

Correlation between peripapillary macular fiber layer thickness and visual acuity in patients with open-angle glaucoma
par: Kazuko Omodaka, et autres
Publié: (2010)

Effects of intravitreal bevacizumab on reduced visual acuity and macular thickness secondary to branch retinal vein occlusion
par: Eltutar K, et autres
Publié: (2013)

Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial
par: Can Cui, et autres
Publié: (2021)

Comparison of macular thickness by optical coherence tomography measurements after uneventful phacoemulsification using ketorolac tromethamine, nepafenac, vs a control group, preoperatively and postoperatively
par: Stock RA, et autres
Publié: (2018)

Antibacterial efficacy of prophylactic besifloxacin 0.6% and moxifloxacin 0.5% in patients undergoing cataract surgery
par: Bucci FA Jr, et autres
Publié: (2015)

Crystal structure and dielectric properties of layered perovskite-like solid solutions Bi3−x Gdx TiTaO9 (x = 0.0, 0.1, 0.2, 0.3) with high Curie temperature
par: S. V. Zubkov
Publié: (2021)

Amplitude mode in the planar triangular antiferromagnet Na0.9MnO2
par: Rebecca L. Dally, et autres
Publié: (2018)

Efficacy of the travoprost/timolol fixed combination versus the concomitant use of travoprost 0.004% and timolol 0.1% gel formulation
par: Kozobolis V, et autres
Publié: (2018)

Optical properties of chalcogenide (As2S1.5Se1.5)0.99:Sn0.01 thin films
par: Iaseniuc, Oxana, et autres
Publié: (2010)

Tid og rum - børn og køn
par: Harriet Bjerrum Nielsen
Publié: (2015)